Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis
- 1 June 2013
- journal article
- clinical trial
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 72 (6) , 908-910
Abstract
Objective The combination of methotrexate (MTX) with infliximab can modify infliximab pharmacokinetics and lower the incidence of antibodies against infliximab (ATIs). We hypothesised that the pharmacokinetic interaction between MTX and infliximab is related to activation of MTX to immunosuppressive MTX polyglutamates (MTXPGs). Methods Adult patients with rheumatoid arthritis receiving weekly MTX with infliximab for more than 3 months were enrolled in a cross-sectional study. Blood was collected at trough before the infusion of infliximab. Red blood cell (RBC) MTXPGs were measured using liquid chromatography, and circulating levels of infliximab were measured using a cell-based assay. ATIs were measured using enzyme immunoassays. Statistical analyses consisted of multiple regression and Wilcoxon tests. Results In the 61 patients enrolled in the study, ATIs were detected in 11 (18%). Regression analyses revealed that lower infliximab levels (median 3.3 µg/ml) were associated with the presence of ATIs and lower RBC MTXPG levels (median 28 nmol/l) (pConclusions These hypothesis-generating data indicate that MTXPGs are associated with infliximab pharmacokinetics and ATI formation.Keywords
This publication has 16 references indexed in Scilit:
- Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent mannerAnnals of the Rheumatic Diseases, 2012
- Transient Low-Dose Methotrexate Induces Tolerance to Murine Anti-Thymocyte Globulin and Together They Promote Long-Term Allograft SurvivalThe Journal of Immunology, 2012
- Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritisRheumatology, 2011
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritisArthritis Research & Therapy, 2009
- Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximabArthritis & Rheumatism, 2006
- Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate‐treated rheumatoid arthritisArthritis & Rheumatism, 2004
- The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.Journal of Clinical Investigation, 1998